Federated Hermes’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$655 Sell
81
-272,990
-100% -$2.21M ﹤0.01% 2026
2025
Q1
$2.29M Buy
273,071
+1,237
+0.5% +$10.4K ﹤0.01% 907
2024
Q4
$2.15M Buy
271,834
+5,849
+2% +$46.3K ﹤0.01% 914
2024
Q3
$2.21M Buy
265,985
+451
+0.2% +$3.75K ﹤0.01% 909
2024
Q2
$1.69M Sell
265,534
-6,003
-2% -$38.1K ﹤0.01% 963
2024
Q1
$1.65M Buy
271,537
+193,363
+247% +$1.17M ﹤0.01% 991
2023
Q4
$475K Sell
78,174
-85
-0.1% -$517 ﹤0.01% 1355
2023
Q3
$330K Buy
+78,259
New +$330K ﹤0.01% 1443
2022
Q3
Sell
-7,535
Closed -$24K 2141
2022
Q2
$24K Sell
7,535
-7,823
-51% -$24.9K ﹤0.01% 1746
2022
Q1
$64K Buy
15,358
+19
+0.1% +$79 ﹤0.01% 1708
2021
Q4
$73K Sell
15,339
-17,365
-53% -$82.6K ﹤0.01% 1749
2021
Q3
$175K Buy
32,704
+5,122
+19% +$27.4K ﹤0.01% 1685
2021
Q2
$141K Sell
27,582
-4,897
-15% -$25K ﹤0.01% 1735
2021
Q1
$218K Sell
32,479
-92,507
-74% -$621K ﹤0.01% 1684
2020
Q4
$572K Buy
124,986
+1,705
+1% +$7.8K ﹤0.01% 1494
2020
Q3
$479K Buy
123,281
+10,199
+9% +$39.6K ﹤0.01% 1486
2020
Q2
$538K Sell
113,082
-1,351,577
-92% -$6.43M ﹤0.01% 1464
2020
Q1
$5.1M Buy
1,464,659
+1,047,868
+251% +$3.65M 0.02% 622
2019
Q4
$2.01M Buy
416,791
+220,695
+113% +$1.06M ﹤0.01% 1022
2019
Q3
$568K Buy
196,096
+195,328
+25,433% +$566K ﹤0.01% 1426
2019
Q2
$6K Sell
768
-106
-12% -$828 ﹤0.01% 1947
2019
Q1
$12K Sell
874
-78
-8% -$1.07K ﹤0.01% 1839
2018
Q4
$13K Sell
952
-102
-10% -$1.39K ﹤0.01% 1832
2018
Q3
$23K Sell
1,054
-175
-14% -$3.82K ﹤0.01% 1824
2018
Q2
$20K Buy
+1,229
New +$20K ﹤0.01% 1793